When examining the FGFR2 fusions in our study, we observed a distinction in frequency between fluke-associated cases (1/121) versus non–fluke-associated cases (11/95; P = .0006), indicating that FGFR fusions were almost exclusively detected in non–fluke-associated CCA. The gene discussed is FGFR2; the disease is cholangiocarcinoma.